Clinical Trial

HEARTBEAT-TROP. Polyethylene Glycol Precipitation to Unmask Macrotroponin

Study acronym: MACRO-TROP
Recruiting
View on ClinicalTrials.gov →
Summary
Troponin elevation can, among others, be due to myocardial infarction, acute inflammation or structural heart disease. Formation of macrocomplexes against troponin is an underestimated cause for persistent troponin elevation. Polyethlylene glycol precipitation (PEG) can differentiate macrotroponin from real troponin elevation, but cut-off values for PEG have not been established. PEG is analyzed in patients with acute coronary syndrome undergoing invasive coronary angiography and compared to healthy marathon runners who have undergone cardiological pre-participation screening and have rested for 24 hours.
Trial Details
NCT Number NCT07726420
Lead Sponsor Technical University of Munich
Conditions Diagnoses Disease
Enrollment 160 participants
Start Date 2026-07-15
Primary Completion 2027-07-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-24